Immune cell score in pancreatic cancer-comparison of hotspot and whole-section techniques.

An immune cell score (ICS) was introduced for predicting survival in pancreatic ductal adenocarcinoma (PDAC). Few studies have compared different methods of evaluating immune infiltrate. This study compared ICSs determined in whole sections or tissue microarray-like hotspots for predicting survival...

Descripción completa

Detalles Bibliográficos
Publicado en:Virchows Archiv: European Journal of Pathology Vol. 474; no. 6; pp. 691 - 700
Autores principales: Tahkola, Kyösti, Leppänen, Joni, Ahtiainen, Maarit, Väyrynen, Juha, Haapasaari, Kirsi-Maria, Karttunen, Tuomo, Kellokumpu, Ilmo, Helminen, Olli, Böhm, Jan
Formato: Journal Article
Publicado: Springer Nature Jun2019
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=137077679&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 137077679
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        09456317
        O1Z
      jtl: Virchows Archiv: European Journal of Pathology
      issn: 09456317
      maglogo: N
    pubinfo:
      dt: Jun2019
      vid: 474
      iid: 6
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        137077679
        137077679
        NLM30843106
        10.1007/s00428-019-02549-1
        NLM30843106
        137077679
      ppf: 691
      ppct: 9
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Immune cell score in pancreatic cancer-comparison of hotspot and whole-section techniques.
      aug:
        au:
          Tahkola, Kyösti
          Leppänen, Joni
          Ahtiainen, Maarit
          Väyrynen, Juha
          Haapasaari, Kirsi-Maria
          Karttunen, Tuomo
          Kellokumpu, Ilmo
          Helminen, Olli
          Böhm, Jan
        affil: Department of Surgery, Central Finland Central Hospital, Jyvaskyla, Finland
      sug:
        subj:
          Adenocarcinoma Pathology
          Carcinoma, Ductal Pathology
          Pancreatic Neoplasms Pathology
          Middle Age
          Prognosis
          Survival
          Retrospective Design
          Adult
          Aged
          Aged, 80 and Over
          Carcinoma, Ductal Immunology
          Pancreatic Neoplasms Immunology
          Male
          Female
          Adenocarcinoma Immunology
          Pancreatic Neoplasms Diagnosis
          Middle Aged: 45-64 years
          Adult: 19-44 years
          Aged: 65+ years
          Aged, 80 & over
          Male
          Female
      ab: An immune cell score (ICS) was introduced for predicting survival in pancreatic ductal adenocarcinoma (PDAC). Few studies have compared different methods of evaluating immune infiltrate. This study compared ICSs determined in whole sections or tissue microarray-like hotspots for predicting survival after PDAC surgery. We included in 79 consecutive patients from a single geographical area that underwent surgery for PDAC (R0/R1, stages I-III). We performed digital image analyses to evaluate CD3 and CD8 staining. ICSs were classified as low, moderate, or high, based on the numbers of immune cells in the tumour core and invasive margin. We compared ICS groups determined with the hotspot and whole-section techniques. Associations between ICS and survival were analysed with Cox regression models, adjusted for sex, age, tumour stage, differentiation grade, perineural invasion, and resection radicality. In hotspot ICS analysis, 5-year overall survival rates for low, moderate, and high groups were 12.1%, 26.3%, and 26.8%, respectively (p = 0.193). In whole-section analyses, overall survival rates were 5.3%, 26.4%, and 43.8%, respectively (p = 0.030). In the adjusted Cox model, whole-section ICS groups were inversely associated with the overall mortality hazard ratio (HR): low, moderate, and high ICS groups had HRs of 1.00, 0.42 (95% CI 0.20-0.88), and 0.27 (95% CI 0.11-0.67), respectively. The number of immune cells per square millimetre in the tumour core and the invasive margin were significantly higher and had a wider range in hotspots than in whole-tissue sections. Accordingly, ICS could predict survival in patients with PDAC after surgery. Whole tissue section ICSs exhibited better prognostic value than hotspot ICSs.
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N